167
Participants
Start Date
April 30, 2011
Primary Completion Date
May 31, 2014
Study Completion Date
April 30, 2015
VGX 3100
1ml of VGX-3100 delivered IM followed by electroporation at Day 0, Week 4 and Week 12.
Placebo
1ml of placebo delivered IM followed by electroporation at Day 0, Week 4 and Week 12.
CELLECTRA™-5P
CELLECTRA™-5P is used for electroporation following IM delivery of VGX 3100 or placebo on Day 0, Week 4 and Week 12.
Victoria
Batumi
Cape Town
Bloemfontein
The Bronx
Port Jefferson
Philadelphia
Baltimore
Richmond
Winston-Salem
Raleigh
Myrtle Beach
Fort Lauderdale
Boynton Beach
Sarasota
Columbus
Saginaw
Missoula
Oklahoma City
Lakewood
Pleasant Grove
Sandy City
Murray
Phoenix
Tucson
Los Angeles
La Mesa
Colton
Eugene
Renton
Spokane
Jaipur
Pune
Bangalore
Montreal
Vancouver
Tallinn
Tartu
Tbilisi
Kolkata
New Delhi
Seoul
San Juan
Lead Sponsor
Inovio Pharmaceuticals
INDUSTRY